A Pilot Registry for Ultrasound-guided Pharmacopuncture
Safety and Effectiveness of Ultrasound-guided Pharmacopuncture for Spinal Diseases: A Pilot Registry
1 other identifier
observational
50
1 country
3
Brief Summary
A pilot study of prospective resigstry to evaluate the safety and efficacy of ultrasound-guided pharmacopuncture for spinal disorders
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2024
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2024
CompletedFirst Posted
Study publicly available on registry
August 27, 2024
CompletedStudy Start
First participant enrolled
September 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2025
CompletedOctober 2, 2025
September 1, 2024
22 days
July 22, 2024
October 1, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse Event
Adverse events assessment
Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Secondary Outcomes (4)
Spinal pain numeric rating scale
Week 0, Treatment visits up to 12 weeks, and Week 2, 4, 8, 12 follow-ups
Disability index
Week 0, 2, 4, 8, 12
EQ-5D-5L
Week 0, 2, 4, 8, 12
Patient satisfaction
Week 4
Study Arms (1)
Ultrasound-guided pharmacopuncture group
Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment
Interventions
Pharmacopuncture treatment using ultrasound-guidance
Eligibility Criteria
Patients diagnosed with spinal disorders who have undergone ultrasound-guided pharmacopuncture treatment
You may qualify if:
- Individuals diagnosed with spinal disorders (M code and S code based on KCD criteria)
- Outpatients scheduled for ultrasound-guided pharmacopuncture treatment
- Individuals aged 19 years or older and under 70 years
- Individuals who agree to participate in the clinical study and voluntarily sign the consent form
You may not qualify if:
- Individuals who are unable to complete the consent form
- Individuals who are deemed unsuitable for participation in the clinical study by the researcher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Jaseng Hospital of Korean medicine
Seoul, Gangnam-Gu, 135-896, South Korea
Bucheon Jaseng Hospital of Korean Medicine
Bucheon-si, Gyeonggi Province, 14598, South Korea
Daejeon Jaseng Hospital of Korean medicine
Daejeon, Seo-gu, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
In-Hyuk Ha, Dr
Jaseng Medical Foundation
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2024
First Posted
August 27, 2024
Study Start
September 23, 2024
Primary Completion
October 15, 2024
Study Completion
February 7, 2025
Last Updated
October 2, 2025
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share